Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy OKYO Pharma Ltd ADR stock (OKYO)

Learn how to buy OKYO Pharma Ltd ADR stock in 5 easy steps.

OKYO Pharma Ltd ADR is a biotechnology business based in the US. OKYO Pharma Ltd ADR shares (OKYO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.16 – an increase of 9.43% over the previous week. OKYO Pharma Ltd ADR employs 8 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy OKYO Pharma Ltd ADR stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you fund a new account within 30 days
  • Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%

How to buy OKYO Pharma Ltd ADR stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – OKYO. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy OKYO Pharma Ltd ADR stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Product USFST Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Finder score
Stocks, ETFs
$0
$0
N/A
Earn up to $300
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Finder score
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

OKYO Pharma Ltd ADR stock price (NASDAQ: OKYO)

Use our graph to track the performance of OKYO stocks over time.

OKYO Pharma Ltd ADR shares at a glance

Information last updated 2024-12-22.
Latest market close$1.16
52-week range$0.81 - $1.95
50-day moving average $1.07
200-day moving average $1.29
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-0.57

Is it a good time to buy OKYO Pharma Ltd ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OKYO Pharma Ltd ADR price performance over time

Historical closes compared with the close of $1.07 from 2024-12-26

1 week (2024-12-20) 0.94%
1 month (2024-11-27) 2.88%
3 months (2024-09-27) 5.42%
6 months (2024-06-28) -10.08%
1 year (2023-12-28) -43.39%
2 years (2022-12-28) -49.29%
3 years (2021-12-24) N/A
5 years (2019-12-24) N/A

OKYO Pharma Ltd ADR financials

Gross profit TTM $-3,599,629
Return on assets TTM -291.87%
Return on equity TTM -2968.51%
Profit margin 0%
Book value $-0.18
Market Capitalization $36.5 million

TTM: trailing 12 months

OKYO Pharma Ltd ADR share dividends

We're not expecting OKYO Pharma Ltd ADR to pay a dividend over the next 12 months.

OKYO Pharma Ltd ADR share price volatility

Over the last 12 months, OKYO Pharma Ltd ADR's shares have ranged in value from as little as $0.8075 up to $1.95. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OKYO Pharma Ltd ADR's is -3.356. This would suggest that OKYO Pharma Ltd ADR's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, OKYO Pharma Ltd ADR has bucked the trend.

OKYO Pharma Ltd ADR overview

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease; in phase 1 clinical trial for the treatment of neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. The company is also developing OK-201, which is in preclinical trial for the treatment of dry eye disease and neuropathic chronic pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom. .

Frequently asked questions

What percentage of OKYO Pharma Ltd ADR is owned by insiders or institutions?
Currently 27.608% of OKYO Pharma Ltd ADR shares are held by insiders and 2.988% by institutions.
How many people work for OKYO Pharma Ltd ADR?
Latest data suggests 8 work at OKYO Pharma Ltd ADR.
When does the fiscal year end for OKYO Pharma Ltd ADR?
OKYO Pharma Ltd ADR's fiscal year ends in March.
Where is OKYO Pharma Ltd ADR based?
OKYO Pharma Ltd ADR's address is: 14/15 Conduit St, London, United Kingdom, W1S 2XJ
What is OKYO Pharma Ltd ADR's ISIN number?
OKYO Pharma Ltd ADR's international securities identification number is: US6793451088

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site